SOURCE: Ingen Technologies, Inc.
RIVERSIDE, CA--(Marketwire - Jan 10, 2013) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with patented proprietary medical technology for the growing $55 Billion US home healthcare industry, is pleased to announce that its Quebec-Canada export distributor, MMT Inc., has given Ingen verbal commitments of approximately $3 Million in product purchases.
The company received notification from William Mourad, CEO of MMT Inc., specifying that its export partners have agreed to purchase up to $3 Million of Ingen products, inclusive of the Smart Nasal Cannula and Oxyview Flow Meter. The notification further stated that the purchase orders will be sent later this month.
The company is prepared to immediately ship 140,900 units in value of $1.8 Million. These units include 53,500 Oxyview Flow Meters, and 87,400 Smart Nasal Cannulas.
VISIT OUR WEBSITE AT: www.ingen-tech.com or FACT SHEET AT: http://ingen-tech.com/files/documents/ignt-1112.pdf
ANALYST RESEARCH REPORT: http://www.otcmarkets.com/financialReportViewer?symbol=IGNT&id=95782
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.